FDA Issues Suicidality Alert On Antiepileptics

A class-wide relabeling is expected, but Pfizer says that Neurontin and Lyrica show no signs of increased events.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet